Current status of recombinant duck enteritis virus vector vaccine research

Duck enteritis virus (DEV), the pathogen of duck viral enteritis, belongs to the α-herpesvirus subfamily. Like other herpesviruses, it has a large genome with multiple non-coding and non-essential regions for viral replication. It is suitable as a live virus vector for inserting and expressing antig...

Full description

Saved in:
Bibliographic Details
Main Authors: Wen-Feng Jia, An-Ping Wang, Zhi Wu, Xin-Nuo Lei, Yu-Ting Cheng, Shan-Yuan Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Veterinary Science
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fvets.2025.1453150/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832539878901940224
author Wen-Feng Jia
An-Ping Wang
Zhi Wu
Xin-Nuo Lei
Yu-Ting Cheng
Shan-Yuan Zhu
author_facet Wen-Feng Jia
An-Ping Wang
Zhi Wu
Xin-Nuo Lei
Yu-Ting Cheng
Shan-Yuan Zhu
author_sort Wen-Feng Jia
collection DOAJ
description Duck enteritis virus (DEV), the pathogen of duck viral enteritis, belongs to the α-herpesvirus subfamily. Like other herpesviruses, it has a large genome with multiple non-coding and non-essential regions for viral replication. It is suitable as a live virus vector for inserting and expressing antigenic genes from other pathogens to develop multivalent vaccines. With the advancement of molecular biology research and experimental technology, genetic modification of the DEV genome has matured, leading to the successful construction of recombinant DEV live vector vaccines. These vaccines have demonstrated the ability to resist DEV and other pathogens, showing potential as recombinant viral vaccine vectors and playing a crucial role in the development of new avian vaccines. This article provides an overview of the progress of research on recombinant vaccines using DEV as the vector. It includes the biological characteristics of DEV and its advantages and limitations as a vaccine vector, methods for constructing recombinant DEV, the technical platform for efficiently building recombinant DEV, factors affecting the immune protection efficacy of recombinant DEV, and the application of recombinant DEV in vaccine development. Aiming to provide a reference for the development of duck enteritis virus vector-based vaccines.
format Article
id doaj-art-246bff76834743368022b13fe3b13bc7
institution Kabale University
issn 2297-1769
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Veterinary Science
spelling doaj-art-246bff76834743368022b13fe3b13bc72025-02-05T07:32:58ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692025-02-011210.3389/fvets.2025.14531501453150Current status of recombinant duck enteritis virus vector vaccine researchWen-Feng JiaAn-Ping WangZhi WuXin-Nuo LeiYu-Ting ChengShan-Yuan ZhuDuck enteritis virus (DEV), the pathogen of duck viral enteritis, belongs to the α-herpesvirus subfamily. Like other herpesviruses, it has a large genome with multiple non-coding and non-essential regions for viral replication. It is suitable as a live virus vector for inserting and expressing antigenic genes from other pathogens to develop multivalent vaccines. With the advancement of molecular biology research and experimental technology, genetic modification of the DEV genome has matured, leading to the successful construction of recombinant DEV live vector vaccines. These vaccines have demonstrated the ability to resist DEV and other pathogens, showing potential as recombinant viral vaccine vectors and playing a crucial role in the development of new avian vaccines. This article provides an overview of the progress of research on recombinant vaccines using DEV as the vector. It includes the biological characteristics of DEV and its advantages and limitations as a vaccine vector, methods for constructing recombinant DEV, the technical platform for efficiently building recombinant DEV, factors affecting the immune protection efficacy of recombinant DEV, and the application of recombinant DEV in vaccine development. Aiming to provide a reference for the development of duck enteritis virus vector-based vaccines.https://www.frontiersin.org/articles/10.3389/fvets.2025.1453150/fullduck enteritis virusrecombinant vector vaccinegenetic modificationwaterfowl infectious diseaseimmune protection efficacyavian vaccines
spellingShingle Wen-Feng Jia
An-Ping Wang
Zhi Wu
Xin-Nuo Lei
Yu-Ting Cheng
Shan-Yuan Zhu
Current status of recombinant duck enteritis virus vector vaccine research
Frontiers in Veterinary Science
duck enteritis virus
recombinant vector vaccine
genetic modification
waterfowl infectious disease
immune protection efficacy
avian vaccines
title Current status of recombinant duck enteritis virus vector vaccine research
title_full Current status of recombinant duck enteritis virus vector vaccine research
title_fullStr Current status of recombinant duck enteritis virus vector vaccine research
title_full_unstemmed Current status of recombinant duck enteritis virus vector vaccine research
title_short Current status of recombinant duck enteritis virus vector vaccine research
title_sort current status of recombinant duck enteritis virus vector vaccine research
topic duck enteritis virus
recombinant vector vaccine
genetic modification
waterfowl infectious disease
immune protection efficacy
avian vaccines
url https://www.frontiersin.org/articles/10.3389/fvets.2025.1453150/full
work_keys_str_mv AT wenfengjia currentstatusofrecombinantduckenteritisvirusvectorvaccineresearch
AT anpingwang currentstatusofrecombinantduckenteritisvirusvectorvaccineresearch
AT zhiwu currentstatusofrecombinantduckenteritisvirusvectorvaccineresearch
AT xinnuolei currentstatusofrecombinantduckenteritisvirusvectorvaccineresearch
AT yutingcheng currentstatusofrecombinantduckenteritisvirusvectorvaccineresearch
AT shanyuanzhu currentstatusofrecombinantduckenteritisvirusvectorvaccineresearch